So that is terrific, and we thought, all right, as we're trying to solve this problem, clearly we have to think about genetics, we have to think about human testing, but there's a fundamental problem, because right now, stem cell lines, as extraordinary as they are, and lines are just groups of cells, they are made by hand, one at a time, and it takes a couple of months. This is not scalable, and also when you do things by hand, even in the best laboratories, you have variations in techniques, and you need to know, if you're making a drug, that the Aspirin you're going to take out of the bottle on Monday is the same as the Aspirin that's going to come out of the bottle on Wednesday.
Esto es asombroso y pensamos, vale, como intentamos solucionar este problema, está claro que tenemos que pensar en la genética, tenemos que pensar en pruebas con humanos, pero hay un problema fundamental, porque ahora mismo, las líneas de células madre, tan extraordinarias como son, y las líneas solo son grupos de células, se hacen a mano, una a una, y lleva un par de meses hacerlo. esto no es escalable y, además, al hacer cosas a mano, incluso en los mejores laboratorios, existen variaciones en las técnicas y si se desarrolla un fármaco, se necesita saber que la Aspirina que hay en el frasco el lunes es la misma Aspirina que hay en el frasco el miércoles.